Evidence map›Paper›PMID 22068604›Full record

ReviewAmerican journal of physiology. Endocrinology and metabolism2012

Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis.

Cletus Cheyuo, Asha Jacob, Ping Wang

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Ghrelin as an Anti-Sepsis Peptide: Review.Frontiers in immunology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. TRPV1 and SP: key elements for sepsis outcome?British journal of pharmacology · 2013
    Review
  14. In search of acute surgical stress biomarkers: Is ghrelin a potential candidate?Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cletus CheyuoElmezzi Graduate School of Molecular Medicine, Hofstra North Shore-LIJ Medical School, Manhasset, New York, USA.
Asha Jacob
Ping Wang
Feinstein Institute for Medical Research · US

Funding

Modulation of Hepatocellular Function in SepsisR01GM053008 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WANG, PING · 2001 to 2015
$3.7M
Regulation of Age-Related Inflammation in Septic ShockR01AG028352 · NIA · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI WANG, PING · 2006 to 2010
$1.7M
NIA NIH HHS R01 AG-028352NIGMS NIH HHS R01GM-053008PHS HHS R33 A-1080536
6 · The paper itself

Abstract

Sepsis, a systemic inflammatory response to infection, continues to carry a high mortality despite advances in critical care medicine. Elevated sympathetic nerve activity in sepsis has been shown to contribute to early hepatocellular dysfunction and subsequently multiple organ failure, resulting in a poor prognosis, especially in the elderly. Thus, suppression of sympathetic nerve activity represents a novel therapeutic option for sepsis. Ghrelin is a 28-amino acid peptide shown to inhibit sympathetic nerve activity and inflammation in animal models of tissue injury. Age-related ghrelin hyporesponsiveness has also been shown to exacerbate sepsis. However, the mechanistic relationship between ghrelin-mediated sympathoinhibition and suppression of inflammation remains poorly understood. This review assesses the therapeutic potential of ghrelin in sepsis in the context of the neuroanatomical and molecular basis of ghrelin-mediated suppression of inflammation through inhibition of central sympathetic outflow.

Indexed as

AgingAnimalsAnti-Inflammatory Agents, Non-SteroidalCatecholaminesDrug ResistanceGhrelinHumansMolecular Targeted TherapyMultiple Organ FailureNeuronsSepsisSympathetic Nervous SystemSympatholyticsAnti-Inflammatory Agents, Non-SteroidalCatecholaminesGhrelinSympatholytics

Identifiers

PMID22068604
PMCPMC3287362
OpenAlexW2169183085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.